Live Breaking News & Updates on Carmen Escuriola Ettingshausen

Stay updated with breaking news from Carmen escuriola ettingshausen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) enrolls first patient in the US


Share this article
Share this article
ATLANTA, May 28, 2021 /PRNewswire/ Dr Robert Sidonio and Dr Carmen Escuriola-Ettingshausen have announced that MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) has commenced patient enrollment in the US.
MOTIVATE is a multicenter, investigator-initiated study aiming to capture different approaches used for the management of patients with hemophilia A and inhibitors. It is registered as a non-interventional study in the US (NCT04023019) and as a low-interventional, pragmatic trial in Europe (EudraCT No. 2019-003427-38).
Dr Sidonio, Coordinating Investigator of the study for the US and Canada, commented that We are very excited that patient enrollment in MOTIVATE has begun in the US. The data being collected will be invaluable in progressing our understanding of the efficacy and safety of different therapeutic regimens, bringing us closer to our goal of improving the standard of care for hemophilia ....

United States , Georgia Center , Emory University , Robert Sidonio Jr , Robert Sidonio , Carmen Escuriola Ettingshausen , Hemophilia Of Georgia Center , Coordinating Investigator , Zentrum Rhein Main , Assistant Professor , Clinical Operations , Clotting Disorders , The Motivate Study , ஒன்றுபட்டது மாநிலங்களில் , ஜார்ஜியா மையம் , உணர்ச்சி பல்கலைக்கழகம் , ஹீமோபிலியா ஆஃப் ஜார்ஜியா மையம் , ஒருங்கிணைத்தல் புலனாய்வாளர் , ஜென்திரும் ரைன் பிரதான , உதவியாளர் ப்ரொஃபெஸர் , மருத்துவ செயல்பாடுகள் , உறைதல் கோளாறுகள் ,